CG Oncology Newsroom

CG Oncology Analyst Ratings

BenzingaJun 28 06:32 ET

Analysts Are Bullish on Top NA Stocks: Viking Holdings Ltd (VIK), CG Oncology, Inc. (CGON)

TipRanksMay 28 06:27 ET

CG Oncology Analyst Ratings

BenzingaMay 28 06:27 ET

Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target

MT NewswiresMay 14 08:01 ET

CG Oncology Analyst Ratings

BenzingaMay 13 16:27 ET

CG Oncology Analyst Ratings

BenzingaMay 10 08:28 ET

CG Oncology Analyst Ratings

BenzingaMay 6 06:51 ET

CG Oncology's Cretostimogene Shows Promising Efficacy and Safety in NMIBC Treatment, Merits Buy Rating

TipRanksMay 6 06:20 ET

Buy Rating Justified by CG Oncology's Cretosmogene Efficacy and Market Positioning

TipRanksMay 3 15:21 ET

CG Oncology Analyst Ratings

BenzingaMay 2 12:08 ET

Buy Rating Affirmed for CG Oncology Amidst Bladder Cancer Treatment Landscape and BCG Shortage

TipRanksApr 23 08:31 ET

Buy Rating Affirmed for CG Oncology on Strong Clinical Data and Market Potential

TipRanksApr 4 06:21 ET

CG Oncology Analyst Ratings

BenzingaApr 4 06:10 ET

Buy Rating Justified by CG Oncology's Strong Clinical Trial Results and Promising Cretosimogene Therapy

TipRanksApr 1 07:45 ET

Buy Rating Affirmed for CG Oncology, Inc. on Promising CG0070 Phase 3 Trials and Unmet Medical Need

TipRanksFeb 27 19:35 ET

CG Oncology's CG0070: A Buy Rating on Breakthrough Bladder Cancer Treatment

TipRanksFeb 20 06:45 ET

CG Oncology Analyst Ratings

BenzingaFeb 20 05:25 ET

Buy Rating Affirmed for CG Oncology on Cretostimogene's Clinical Success and Market Potential

TipRanksFeb 19 19:15 ET

CG Oncology Analyst Ratings

BenzingaFeb 14 06:53 ET